Motivations of palliative lung cancer patients to participate in a non-placebo clinical trial (QualFRAG)
Motivations of palliative lung cancer patients to participate in a non-placebo clinical trial (QualFRAG)
Palliative care lung cancer patients are underrepresented
in oncology trials and very little is understood about
their experiences of participating in clinical trials. The FRAGMATIC
trial is the largest lung cancer study in the UK and is investigating
the effects of Fragmin (a self-injected anti-coagulant) in patients
with lung cancer. This current study (QualFRAG) is a qualitative substudy
of the FRAGMATIC trial. QualFRAG aims to explore patients’
experiences of participating in a non-placebo trial, including their
motivations to take part.
S36
Griffiths, Gareth
7fd300c0-d279-4ff6-842d-aa1f2b9b864d
Edwards, M.
c9675e8c-09da-42df-be29-6be2dd524822
Sivell, S.
4be73728-8835-4842-938c-dfd79dc8fc87
Harrop, E.
1c2dc92d-1544-4c14-b8eb-ee31f4f37392
Nelson, A.
6207f97d-f330-408b-8e2b-b33d1e13e9ae
Hood, K.
8c29d010-1db0-41ff-8c9d-d5fe61eb118e
Byrne, A.
45e85ff4-1395-4f59-9adf-5d621f3c8994
Moore, B.
6763cb8d-1326-47d7-bec8-033f55f3bc9f
Ahmed, S
a5507120-ae95-4d45-a68f-e07396ee224a
Noble, S.
e90970b1-8c8d-4a94-a5a2-c920e85ce6bc
2012
Griffiths, Gareth
7fd300c0-d279-4ff6-842d-aa1f2b9b864d
Edwards, M.
c9675e8c-09da-42df-be29-6be2dd524822
Sivell, S.
4be73728-8835-4842-938c-dfd79dc8fc87
Harrop, E.
1c2dc92d-1544-4c14-b8eb-ee31f4f37392
Nelson, A.
6207f97d-f330-408b-8e2b-b33d1e13e9ae
Hood, K.
8c29d010-1db0-41ff-8c9d-d5fe61eb118e
Byrne, A.
45e85ff4-1395-4f59-9adf-5d621f3c8994
Moore, B.
6763cb8d-1326-47d7-bec8-033f55f3bc9f
Ahmed, S
a5507120-ae95-4d45-a68f-e07396ee224a
Noble, S.
e90970b1-8c8d-4a94-a5a2-c920e85ce6bc
Griffiths, Gareth, Edwards, M., Sivell, S., Harrop, E., Nelson, A., Hood, K., Byrne, A., Moore, B., Ahmed, S and Noble, S.
(2012)
Motivations of palliative lung cancer patients to participate in a non-placebo clinical trial (QualFRAG).
.
Record type:
Conference or Workshop Item
(Poster)
Abstract
Palliative care lung cancer patients are underrepresented
in oncology trials and very little is understood about
their experiences of participating in clinical trials. The FRAGMATIC
trial is the largest lung cancer study in the UK and is investigating
the effects of Fragmin (a self-injected anti-coagulant) in patients
with lung cancer. This current study (QualFRAG) is a qualitative substudy
of the FRAGMATIC trial. QualFRAG aims to explore patients’
experiences of participating in a non-placebo trial, including their
motivations to take part.
This record has no associated files available for download.
More information
Published date: 2012
Identifiers
Local EPrints ID: 413147
URI: http://eprints.soton.ac.uk/id/eprint/413147
PURE UUID: 3fed89f2-75b9-47fc-976b-74679dc4a3cb
Catalogue record
Date deposited: 16 Aug 2017 16:30
Last modified: 23 Jul 2022 02:09
Export record
Contributors
Author:
M. Edwards
Author:
S. Sivell
Author:
E. Harrop
Author:
A. Nelson
Author:
K. Hood
Author:
A. Byrne
Author:
B. Moore
Author:
S Ahmed
Author:
S. Noble
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
